Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Windham Venture Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
Windham Venture Partners

Windham Venture Partners

Operating

Windham: A NYC-based venture capital firm, founded in 2006, specializing in healthcare and medical investments.

Location
New York City, NY, US
Founded
2006
Firm
Compare
Portfolio
Employees
Website

Investments

Alto Neuroscience
Alto Neuroscience

Total Raised

$239.3M

Rounds

10

Series C$45MNovember 2023
Series B$35MOctober 2022
Series A$32MMay 2021
Clever Care Health Plan
Clever Care Health Plan

Total Raised

$139M

Rounds

5

Series C$42MMarch 2023
Series B$71MSeptember 2021
SubjectWell
SubjectWell

Total Raised

$46.8M

Rounds

6

Series B$35MOctober 2022
Series A$10MJune 2019
Valera Health
Valera Health

Total Raised

$71.9M

Rounds

8

Series Unknown$45MOctober 2022
Series Unknown$15MNovember 2021
Series Unknown$3.8MFebruary 2021
Vergent Bioscience
Vergent Bioscience

Total Raised

$34.4M

Rounds

3

Series B$21.5MOctober 2022
Delfi Diagnostics
Delfi Diagnostics

Total Raised

$330.5M

Rounds

3

Series B$225MJuly 2022
Series A$100MJanuary 2021
Seed$5.5MAugust 2019
Neuspera Medical
Neuspera Medical

Total Raised

$111.9M

Rounds

4

Series C$65MJuly 2021
Series B$12MFebruary 2019
Personal Genome Diagnostics
Personal Genome Diagnostics

Total Raised

$244.7M

Rounds

6

Series C$103MFebruary 2021
Willow
Willow

Total Raised

$144.3M

Rounds

8

Series C$55MSeptember 2020
RxWare
RxWare

Total Raised

$10.6M

Rounds

5

Series A$6MJanuary 2020
ChromaCode
ChromaCode

Total Raised

$94M

Rounds

6

Series C$28MDecember 2019
Science Exchange
Science Exchange
Acquired

Total Raised

$77.5M

Rounds

7

Series B$20MOctober 2019
DebtOctober 2019
Cvrx
Cvrx
Public

Total Raised

$390.6M

Rounds

10

Series G$93MAugust 2019
andros
andros

Total Raised

$39.9M

Rounds

6

Series B$14MJune 2019
Nuvaira
Nuvaira

Total Raised

$204M

Rounds

10

Series E$79MFebruary 2019